Search Results

- Company listed in Research and Markets’ announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - “U.S. breast cancer screening and diagnostic [device] market was valued at $1.55 billion in 2024 and is anticipated to reach $2.34 billion by the end of 2030, at a CAGR of 7.05% during the forecast period 2024-20301"- -Report supports Company’s regulatory strategy for IzoView Breast CT, reinforces high demand for new breast imaging modalities, strengthens the potential for rapid market adoption and significant market share -

According to the latest research by InsightAce Analytic, the Global Cancer Stem Cells Market is valued at US$ 2.1 Bn in 2023, and it is expected to reach US$ 4.5 Bn by 2031, with a CAGR of 9.7% during the forecast period of 2024-2031.

Frontotemporal Dementia Market Outlook 2025-2035:

Small Cell Lung Cancer Market Outlook 2025-2035:

SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.

ValGenesis, Inc. and Life Science Consulting Pvt. Ltd. have partnered to provide best-in-class digital validation solutions to enhance compliance and quality across life sciences disciplines such as production, quality control and assurance, information technology, and research and development.

Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a Duchenne muscular dystrophy candidate.